Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00764530 · ClinicalTrials.gov registry record · NA
Cementless Alumina-Alumina Total Hip and Hybrid
A NA study, sponsored by Encore Medical, L.P..
- Completed
- Registry status
- NA
- Development phase
- 342
- Enrollment target
NCT00764530 is a NA study that has completed, run by Encore Medical, L.P.. The registered enrollment target is 342 participants.
The verdict
NCT00764530, a NA study, has completed, sponsored by Encore Medical, L.P..
- COMPLETED
- Registry status
- NA
- Development phase
- 342 participants
- Enrollment target
Study Summary
Evaluate the safety and efficacy of the CeramTec Acetabular Alumina Insert and CeramTec Alumina head when used with the Foundation Porous Coated Acetabular Shell and an Encore hip stem.
Interventions
- DEVICE Alumina/Alumina
- DEVICE Standard
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 342 participants |
| Start Date | 2003-11 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00764530
The ClinicalTrials.gov registry entry for NCT00764530 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 342 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Encore Medical, L.P., which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Alumina/Alumina is the first listed.
NCT00764530 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00764530 about?
NCT00764530 is a clinical study titled "Cementless Alumina-Alumina Total Hip and Hybrid". Evaluate the safety and efficacy of the CeramTec Acetabular Alumina Insert and CeramTec Alumina head when used with the Foundation Porous Coated Acetabular Shell and an Encore hip stem.
What is the current status of trial NCT00764530?
This trial is currently completed. It is a NA study. The enrollment target is 342 participants. The study started on 2003-11. Estimated completion is 2015-01.
What interventions are being tested in trial NCT00764530?
The interventions under investigation include: Alumina/Alumina (DEVICE), Standard (DEVICE).
Who is sponsoring clinical trial NCT00764530?
This trial is sponsored by Encore Medical, L.P., which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.